Records containing: Osteogenesis Imperfecta
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-24Investigations of Bone-Related Connective Tissue Disorders
-
CLINICAL_TRIALS study record update · 2026-04-24Multicenter, Safety Follow-up Study to Assess Safety of Prior Treatment With Romosozumab in Children and Adolescents With Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2026-04-24Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2026-04-03A Phase 3, Open-Label, Multicenter, Randomized Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2026-03-13An Open-label Phase 3 Study of Setrusumab in Pediatric Japanese Subjects With Osteogenesis Imperfecta Type I, III, or IV
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-02Cardiopulmonary Outcomes in Osteogenesis Imperfecta: BBD7708
-
CLINICAL_TRIALS study record update · 2026-02-25An Open-label, Randomized, Active-Controlled, Phase 3 Study of Setrusumab Compared With Bisphosphonates in Pediatric Subjects With Osteogenesis Imperfecta Types I, III or IV
-
CLINICAL_TRIALS study record update · 2026-02-25An Operationally Seamless, Randomized Phase 2/3 Study Consisting of a Phase 2 Single-Blind, Dose-Evaluation Phase and a Phase 3 Double-Blind, Placebo-Controlled Phase to Assess the Efficacy and Safety of Setrusumab in Subjects With Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2026-02-23A Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and the Genotype-Phenotype Correlation
-
CLINICAL_TRIALS study record update · 2026-02-17Observational Study for the Assessment of Bone Mineral Density (BMD) Using REMS Technology
-
CLINICAL_TRIALS study record update · 2026-01-27Dental Malocclusion and Craniofacial Development in OI
-
CLINICAL_TRIALS study record update · 2026-01-26A Single Center Post-market Clinical Follow-up (PMCF) Observational Study Evaluating the Clinical Performance and the Safety Profile of the JuniOrtho™ Telescopic Intramedullary Nail (JTIN) for the Treatment of Pediatric Patients Suffering From Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2025-12-17Evaluation of Cardiac Function and Morphology in Individuals With Osteogenesis Imperfecta: Prospective Observational Study
-
CLINICAL_TRIALS study record update · 2025-12-15Effects of Bisphosphonates on OI-Related Hearing Loss: A Pilot Study
-
CLINICAL_TRIALS study record update · 2025-12-03Use of Clear Aligners for the Treatment of Dental Malocclusion in Individuals With Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2025-12-01Cross-Linked Collagen Peptides as a Urinary Biomarker of OI Pathobiology
-
CLINICAL_TRIALS study record update · 2025-11-20Registry of Osteogenesis Imperfecta That Collects Clinical, Functional, Genetic, Genealogical, Imaging, Surgical, Quality of Life Data. Data is Linked to Patients Biological Samples, When Available
-
CLINICAL_TRIALS study record update · 2025-10-29A Phase 1/2 Study to Examine the Safety and Preliminary Efficacy of Mesenchymal Stromal Cells on Linear Growth and Bone Health Parameters in Children With Type 3 Osteogenesis Imperfecta (OI)
-
CLINICAL_TRIALS study record update · 2025-09-17Treatment of Osteogenesis Imperfecta With Parathyroid Hormone and Zoledronic Acid
-
CLINICAL_TRIALS study record update · 2025-09-15Pediatric Arthropathy Beyond Inflammation: Clinical Spectrum and Diagnostic Approach at Assiut University Children Hospital
-
CLINICAL_TRIALS study record update · 2025-09-12An Exploratory, Open Label, Multiple Dose, Multicentre Phase I/II Trial Evaluating Safety and Efficacy of Postnatal or Prenatal and Postnatal Intravenous Administration of Allogeneic Expanded Fetal Mesenchymal Stem Cells for the Treatment of Severe Osteogenesis Imperfecta Compared With a Combination of Historical and Untreated Prospective Controls
-
CLINICAL_TRIALS study record update · 2025-09-12Audio-vestibular Evaluation of Children and Young Adults With Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2025-09-11A Phase 1b, Single Ascending Dose, Randomized, Double-blind Study to Evaluate the Safety, Tolerability, and Activity of SAR439459 in Adults With Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2025-09-10Evaluation of the Benefits of Adaptive Physical Activity in Children and Adolescents With Osteogenesis Imperfecta
-
CLINICAL_TRIALS study record update · 2025-09-04Epigenetic Regulation of Osteogenesis Imperfecta Severity : miROI Study